Our leadership

US BioPharmaceuticals leadership team

Rick R. Suárez

Senior Vice President, US President and Head of US BioPharmaceuticals Business Unit
Elizabeth Bodin

Vice President, US Cardiovascular, Renal & Metabolic Diseases 
Kevin Durning

US Chief Financial Officer and Vice President, Finance
 
Chris Mancill

Senior Vice President, Market Access
 
Miroslav (Miro) Sokolov

Vice President, US Innovation and Business Excellence (IBEX)
Mariam Koohdary

Deputy General Counsel, BioPharmaceuticals
 
Dan Wygal

Vice President, US Corporate Affairs
 
Colleen Kempf

Head of Ethics & Compliance, US BioPharmaceuticals
 
Tiffany Davis

Vice President, Human Resources, US BioPharmaceuticals
 
César Cerezo

Vice President, US Medical, BioPharmaceuticals
James Teague

Vice President, US Respiratory, Immunology, Vaccines and Immune Therapies

Jim Fox

Senior Vice President, Americas Supply Operations

US Oncology leadership team

Mohit Manrao

Senior Vice President, US Oncology Business Unit
 
Carlos Doti

Vice President, Head of Medical Affairs, US Oncology Business Unit
Nancy Ghattas

Vice President, Head of Immuno-Oncology and Gastrointestinal (GI) Tumors Franchise, US Oncology Business Unit
Alison Dziarmaga

Vice President, US Franchise Head, Breast Cancer, AstraZeneca
Eder Martins

Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit
 
Nilsa Sanchez

Vice President, Head of Hematology Franchise for US Oncology at AstraZeneca
Bruce Wilson

Vice President, Head of Oncology Care and Access, US Oncology Business Unit
Daniele Paone

Vice President, Head of DNA Damage Repair, Gynecological and Genitourinary Cancer Franchise, US Oncology Business Unit